about
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Dr...
Read More
29.33
0.37
(1.28%)
1.8M
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
TG Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..